In the Media

Participants were able to stop treatment after achieving amyloid plaque clearance and experience lasting results.

The experimental drug slowed cognitive decline in patients with early-stage disease, but brain bleeding and swelling remain concerns

Dustin Hammers, PhD, provided commentary on a study comparing traditional cognitive screening methods and the Linus Health Digital Clock and Recall test.

After lecanemab, donanemab is the second drug that works best if Alzheimer's patients receive it before any symptoms arise.

Sensitivity and specificity of Early Autism Evaluation Hub system was 81.5 and 82.4 percent, respectively.

A new study discovered a link between alcohol use disorders (AUDs) and alteration of a group of genes known to influence neuronal plasticity and pain perceptions.

An estimated 16 million people in the United States have alcohol use disorders (AUDs), according to the National Institutes on Alcohol Abuse and Alcoholism (NIAAA).

A cadre of responders, alerted by a text or notification, is a commonsense approach that might save lives, a new study hints

Researchers have identified seven risk factors for early-onset colorectal cancer in males.

The goal of this study was to look carefully at what kind of clinical support well-trained nurses with nursing home experience can provide virtually to support clinical care in the facility.

Patients with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes may be at significantly higher risk of hepatic decompensation and liver cancer, researchers reported.

Up-to-date research using consistent cognitive behavioral treatment for insomnia (CBT-I) methods in adolescents is lacking.